SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
吃鱼
Lv6
2550 积分
2022-07-25 加入
最近求助
最近应助
互助留言
Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity
4天前
已完结
Trastuzumab-deruxtecan: an investigational agent for the treatment of HER2-positive breast cancer
4天前
已完结
Trastuzumab deruxtecan for HER2+ advanced breast cancer
4天前
已完结
Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment
4天前
已完结
Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
25天前
已完结
A network meta-analysis on the efficacy of HER2-targeted agents in combination with taxane-containing regimens for treatment of HER2-positive metastatic breast cancer
28天前
已完结
HER2-targeted regimens after prior trastuzumab for patients with HER2-positive unresectable, locally advanced or metastatic breast cancer: a network meta-analysis of randomized controlled trials
28天前
已完结
Exposure–Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast Cancer
1个月前
已完结
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
1个月前
已完结
Exposure-response relationship of T-DM1: insight into dose optimization for patients with HER2-positive metastatic breast cancer
1个月前
已完结
没有进行任何应助
已经找到了【积分已退回】
1个月前
重新填写求助信息【积分已退回】
1个月前
重新申请【积分已退回】
6个月前
找到了【积分已退回】
6个月前
感谢
10个月前
感谢
1年前
感谢
1年前
感谢
1年前
感谢
1年前
速度真快,感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论